Found 51 matching trials
Candesartan for Migraine Prevention: PHASE2 The main objective of this study is to see whether the favorable preventati...
Show More Location
Tartu University Clinics
Learn More & Join Trial
Open-Label Long-Term Safety and Efficacy Study of Fixed Dose Combination of Nifedipine Gastrointestinal Therapeutic System and Candesartan Cilexetil in Subjects With Moderate to Severe Essential Hypertension PHASE3 This study examines the long term safety and efficacy of the Fixed Dose com...
Show More Location
Multiple Locations
Learn More & Join Trial
Sevicontrol-1: Efficacy and Safety of a Fixed Combination of Olmesartan/ Amlodipine PHASE3 The investigators want to find out whether a recently introduced combinatio...
Show More Learn More & Join Trial
Study of Nifedipine GITS and Candesartan Combination Compared to Monotherapy in Patients With Essential Hypertension PHASE2 The purpose of this study is to determine the blood pressure lowering respo...
Show More Location
Multiple Locations
Treatments Being Tested
Candesartan cilexetil (Atacand), 4 mg Candesartan cilexetil (Atacand), 8 mg Nifedipine GITS (Adalat, BAYA1040), 20 mg Nifedipine GITS (Adalat, BAYA1040), 30 mg Nifedipine GITS (Adalat, BAYA1040), 60 mg Placebo Candesartan cilexetil (Atacand), 16 mg Candesartan cilexetil (Atacand), 32 mg Learn More & Join Trial
Heart Outcomes Prevention Evaluation-3 PHASE4 Heart disease and stroke are major causes of death and disability worldwide...
Show More Location
Hamilton General Hospital
Learn More & Join Trial
Bioequivalence Study of CJ-30059 PHASE1 This study is designed to evaluate the bioequivalence of the two treatments...
Show More Location
Samsung Medical Center
Learn More & Join Trial
Imidapril and Candesartan on Fibrinolysis and Insulin-Sensitivity in Patients With Mild to Moderate Hypertension PHASE3 BACKGROUND The effects of ACE-inhibitors on fibrinolysis are well documente...
Show More Location
University of Pavia
Learn More & Join Trial
Genetic Epidemiology of Responses to Antihypertensives N/A To determine whether measured variation in genes coding for components of v...
Show More Learn More & Join Trial
Host Response Mediators in Coronavirus (COVID-19) Infection - Is There a Protective Effect of Losartan and Other ARBs on Outcomes of Coronavirus Infection? PHASE3 SARS-CoV-2 is a member of a class of viruses: angiotensin converting enzyme...
Show More Location
University of Calgary - Foothills
Learn More & Join Trial
Candesartan Effect in Second Stage Arterial Hypertension PHASE4 To compare the changes in mean sitting DBP from baseline after 4 weeks of t...
Show More Learn More & Join Trial